{"id":68007,"date":"2026-10-30T10:55:46","date_gmt":"2026-10-30T05:25:46","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=68007"},"modified":"2026-10-30T10:55:48","modified_gmt":"2026-10-30T05:25:48","slug":"new-series-of-interactive-cardiology-mcqs-18","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/","title":{"rendered":"New Series of Interactive Cardiology MCQs 18"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<!-- Cardiology MCQs Part 18 (Full 25 Questions) - WordPress Safe Custom HTML Block -->\n<script src=\"https:\/\/cdn.tailwindcss.com?plugins=forms,typography,aspect-ratio\"><\/script>\n<script>\n  tailwind.config = {\n    corePlugins: { preflight: false }\n  }\n<\/script>\n\n<div id=\"mcq18-quiz-wrapper\" class=\"font-sans bg-slate-950 text-slate-100 p-4 md:p-8 rounded-3xl max-w-4xl mx-auto shadow-2xl relative overflow-hidden my-8 border border-solid border-indigo-500\/20\" style=\"box-sizing: border-box;\">\n  \n  <!-- Background Accents -->\n  <div class=\"absolute top-0 left-0 w-full h-full pointer-events-none opacity-10 bg-[radial-gradient(ellipse_at_center,_var(--tw-gradient-stops))] from-indigo-500 via-violet-900 to-slate-950\"><\/div>\n  \n  <!-- Header Banner -->\n  <div class=\"relative text-center pb-6 border-b border-solid border-indigo-500\/25 mb-8\">\n    <div class=\"inline-block bg-gradient-to-r from-violet-500 via-indigo-600 to-purple-600 text-white font-black text-xs md:text-sm px-4 py-1.5 rounded-full uppercase tracking-wider shadow-lg mb-3 animate-pulse\">\n      \ud83e\uddec Advanced Cardiology Series &#8211; Part 18\n    <\/div>\n    <h1 class=\"text-3xl md:text-5xl font-extrabold tracking-tight text-transparent bg-clip-text bg-gradient-to-r from-indigo-300 via-violet-400 to-purple-400 m-0\">\n      Interactive Cardiology MCQs #18\n    <\/h1>\n    <p class=\"text-sm md:text-lg text-slate-300 mt-2 max-w-2xl mx-auto font-medium\">\n      Post-Graduate Level Clinical, Imaging, EP &amp; Cardio-Oncology Masterclass\n    <\/p>\n  <\/div>\n\n  <!-- Real-Time Floating Scoreboard -->\n  <div class=\"sticky top-4 z-40 bg-slate-900\/90 backdrop-blur-md border-2 border-solid border-indigo-500\/40 rounded-2xl p-4 mb-8 shadow-xl flex flex-wrap items-center justify-between gap-4\">\n    <div class=\"flex items-center gap-3\">\n      <div class=\"text-3xl\">\ud83c\udfaf<\/div>\n      <div>\n        <div class=\"text-[10px] uppercase font-extrabold tracking-widest text-indigo-300\">Live Scoreboard<\/div>\n        <div class=\"text-lg md:text-2xl font-black text-violet-300 flex items-center gap-1\">\n          <span id=\"mcq18-correct-count\">0<\/span><span class=\"text-slate-500 text-sm md:text-lg\">\/ 25 Correct<\/span>\n        <\/div>\n      <\/div>\n    <\/div>\n    <div class=\"flex items-center gap-2 bg-slate-950\/80 px-4 py-2 rounded-xl border border-solid border-slate-800\">\n      <span class=\"text-xs font-bold text-slate-400 uppercase tracking-wider\">Progress:<\/span>\n      <div class=\"w-24 md:w-36 bg-slate-800 h-3 rounded-full overflow-hidden\">\n        <div id=\"mcq18-progress-bar\" class=\"bg-gradient-to-r from-indigo-500 to-violet-500 h-full w-0 transition-all duration-300 rounded-full\"><\/div>\n      <\/div>\n      <span class=\"text-xs font-bold text-violet-300\"><span id=\"mcq18-answered-count\">0<\/span>\/25<\/span>\n    <\/div>\n  <\/div>\n\n  <!-- Quiz Questions Container -->\n  <div class=\"space-y-8 relative\">\n\n    <!-- Q1 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q1<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with chronic Heart Failure with Reduced Ejection Fraction (HFrEF) is being transitioned from an ACE inhibitor (Enalapril) to an ARNI (Sacubitril\/Valsartan). What is the strictly mandated washout protocol to prevent life-threatening angioedema?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"12 hours is insufficient and carries a high risk of angioedema. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">A) A 12-hour washout period is required.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"There is no washout period required when switching from an ARB to an ARNI, but this patient is on an ACE inhibitor. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">B) No washout period is required; the next dose can be replaced immediately.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Sacubitril (a neprilysin inhibitor) and ACE inhibitors both prevent the breakdown of bradykinin. Taking them together, or too closely in time, dramatically increases the risk of severe angioedema. A strict 36-hour washout period is mandatory when switching from an ACE inhibitor to an ARNI. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">C) A strict 36-hour washout period is mandatory.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A 7-day washout is unnecessarily long and leaves the patient without RAAS blockade. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">D) A 7-day washout period is required.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q2 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q2<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During an echocardiogram to evaluate a patient for severe Aortic Stenosis, the sonographer reports the Dimensionless Index (DI). What DI cutoff value is highly indicative of severe aortic stenosis?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A DI &gt; 0.50 indicates a normal or mildly stenotic aortic valve. Reference: 2017 ASE Guidelines for the Clinical Application of Echocardiography.\">A) DI &gt; 0.50<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A DI of 0.35 suggests moderate aortic stenosis. Reference: 2017 ASE Guidelines for the Clinical Application of Echocardiography.\">B) DI between 0.30 and 0.40<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The Dimensionless Index (DI) is the ratio of the LVOT velocity-time integral (VTI) to the Aortic Valve VTI (or peak velocities). It is particularly useful when LVOT diameter cannot be accurately measured. A DI &lt; 0.25 strongly correlates with a severe aortic valve area (&lt; 1.0 cm\u00b2). Reference: 2017 ASE Guidelines for the Clinical Application of Echocardiography.\">C) DI &lt; 0.25<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While &lt; 0.15 is extremely critical, the validated cutoff threshold for 'severe' starts at &lt; 0.25. Reference: 2017 ASE Guidelines for the Clinical Application of Echocardiography.\">D) DI &lt; 0.15<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q3 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q3<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In a patient with Atrial Fibrillation, an ECG shows an intermittently widened QRS complex. This aberrant conduction typically occurs when a long R-R interval is followed immediately by a short R-R interval. What is this phenomenon called?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Wolff-Parkinson-White involves a permanent anatomical accessory pathway, not rate-dependent refractoriness. Reference: Chou's Electrocardiography in Clinical Practice.\">A) Wolff-Parkinson-White Syndrome<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Brugada syndrome presents with coved ST elevation in V1-V2, not rate-dependent aberrancy in AFib. Reference: Chou's Electrocardiography in Clinical Practice.\">B) Brugada Phenomenon<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The Ashman phenomenon describes aberrant ventricular conduction (most commonly an RBBB morphology) due to a change in the refractory period of the bundle branches. The refractory period lengthens with a long R-R interval; if a premature beat (short R-R) follows closely, one of the bundles (usually the right) is still refractory, causing a wide complex beat that mimics PVCs. Reference: Chou's Electrocardiography in Clinical Practice.\">C) Ashman Phenomenon<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Wenckebach involves progressive PR lengthening culminating in a dropped beat, not wide-complex aberrancy. Reference: Chou's Electrocardiography in Clinical Practice.\">D) Wenckebach Periodicity<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q4 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q4<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient undergoing chemotherapy with Doxorubicin (an anthracycline) is being monitored for cardiotoxicity. Which of the following statements correctly characterizes anthracycline-induced cardiomyopathy?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Anthracycline cardiotoxicity (Type I) is classically dose-dependent, cumulative, and causes irreversible myocardial necrosis and fibrosis, leading to permanent HFrEF. (Contrasts with Trastuzumab\/Type II, which is not dose-dependent and is largely reversible). Reference: 2022 ESC Guidelines on cardio-oncology.\">A) It is classically dose-dependent, cumulative, and involves irreversible myocyte destruction.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes Type II cardiotoxicity, classically seen with Trastuzumab (Herceptin). Reference: 2022 ESC Guidelines on cardio-oncology.\">B) It is not dose-dependent and is generally completely reversible upon cessation of the drug.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While possible, acute fulminant myocarditis is much more characteristic of Immune Checkpoint Inhibitors (e.g., Nivolumab). Reference: 2022 ESC Guidelines on cardio-oncology.\">C) It typically presents as a fulminant, T-cell mediated acute myocarditis during the first infusion.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Anthracyclines cause severe systolic dysfunction, not severe primary diastolic dysfunction with a preserved EF. Reference: 2022 ESC Guidelines on cardio-oncology.\">D) It predominantly causes restrictive cardiomyopathy with severe diastolic dysfunction and preserved EF.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q5 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q5<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Cardiac PET imaging with 13N-ammonia and 18F-FDG is considered the gold standard for assessing myocardial viability. Which imaging pattern confirms the presence of viable, hibernating myocardium?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A 'matched defect' (low perfusion, low metabolism) indicates dead scar tissue (completed infarction), not viable hibernating myocardium. Reference: ASNC Imaging Guidelines for Nuclear Cardiology.\">A) Decreased perfusion (13N-ammonia) matching decreased metabolism (18F-FDG).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"A 'mismatch' pattern defines hibernating, viable myocardium. The tissue has decreased rest perfusion (low 13N-ammonia uptake) due to chronic ischemia, but it remains alive and switches its metabolism to glycolysis, showing preserved or increased glucose uptake (high 18F-FDG). This tissue will recover function if revascularized. Reference: ASNC Imaging Guidelines for Nuclear Cardiology.\">B) Decreased perfusion (13N-ammonia) with preserved or increased metabolism (18F-FDG).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This represents normal, healthy myocardium (or 'reverse mismatch' in some artifact\/LBBB scenarios), not hibernating myocardium. Reference: ASNC Imaging Guidelines for Nuclear Cardiology.\">C) Normal perfusion (13N-ammonia) with absent metabolism (18F-FDG).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This indicates totally normal, healthy myocardium. Reference: ASNC Imaging Guidelines for Nuclear Cardiology.\">D) Increased perfusion (13N-ammonia) matching increased metabolism (18F-FDG).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q6 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q6<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Bempedoic acid is a non-statin oral lipid-lowering therapy. What is its precise cellular mechanism of action in reducing LDL cholesterol?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes the mechanism of Ezetimibe. Reference: 2018 AHA\/ACC Guideline on the Management of Blood Cholesterol.\">A) It inhibits the Niemann-Pick C1-Like 1 (NPC1L1) transporter to block intestinal absorption.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes statins. Reference: 2018 AHA\/ACC Guideline on the Management of Blood Cholesterol.\">B) It directly inhibits HMG-CoA reductase.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Bempedoic acid is an inhibitor of ATP citrate lyase (ACL), an enzyme in the cholesterol biosynthesis pathway that operates strictly upstream of HMG-CoA reductase. Notably, it requires activation by an enzyme found in the liver but absent in skeletal muscle, which minimizes muscle-related side effects compared to statins. Reference: 2018 AHA\/ACC Guideline on the Management of Blood Cholesterol.\">C) It inhibits ATP citrate lyase, an enzyme upstream of HMG-CoA reductase.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes PCSK9 inhibitors. Reference: 2018 AHA\/ACC Guideline on the Management of Blood Cholesterol.\">D) It binds to PCSK9 to prevent LDL receptor degradation.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q7 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q7<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During structural heart interventions, the deployment of a Transcatheter Aortic Valve Replacement (TAVR) \u2014 particularly self-expanding platforms like the CoreValve\/Evolut \u2014 carries a notable risk of which specific conduction system abnormality requiring a permanent pacemaker?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"RBBB occurs, but LBBB is vastly more common due to the anatomical position of the left bundle just beneath the aortic annulus. Reference: 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease.\">A) New-onset Right Bundle Branch Block (RBBB).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The left bundle branch exits the membranous septum just millimeters below the non-coronary and right coronary cusps of the aortic valve. Radial force from the TAVR stent frame frequently compresses this area, making new-onset Left Bundle Branch Block (LBBB) and subsequent high-degree AV block the most common complication requiring a permanent pacemaker. Reference: 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease.\">B) New-onset Left Bundle Branch Block (LBBB) and high-degree AV block.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Sinus node dysfunction is generally unrelated to TAVR deployment because the SA node is in the high right atrium. Reference: 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease.\">C) Sinus arrest due to compression of the Sinoatrial (SA) node.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Fascicular tachycardias are not the primary mechanical complication of TAVR deployment. Reference: 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease.\">D) Left Posterior Fascicular Ventricular Tachycardia.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q8 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q8<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In patients with Wolff-Parkinson-White (WPW) syndrome, Atrioventricular Reentrant Tachycardia (AVRT) can present as orthodromic or antidromic. What is the classic ECG hallmark of an ANTIDROMIC AVRT?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This perfectly describes Orthodromic AVRT (down the AV node, up the accessory pathway). Reference: 2019 ESC Guidelines for the management of patients with supraventricular tachycardia.\">A) A narrow QRS complex tachycardia with no visible delta waves.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"In Antidromic AVRT, the electrical impulse travels ANTEROGRADE (down) the accessory pathway into the ventricles (bypassing the AV node), and RETROGRADE (up) the AV node back to the atria. Because the ventricles are depolarized entirely via cell-to-cell spread outside the His-Purkinje system, it presents as a regular, fully wide-complex tachycardia that is often indistinguishable from Ventricular Tachycardia (VT). Reference: 2019 ESC Guidelines for the management of patients with supraventricular tachycardia.\">B) A regular, fully wide QRS complex tachycardia that mimics Ventricular Tachycardia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"An irregular, wide-complex tachycardia suggests Atrial Fibrillation with pre-excitation (AFib with WPW). Reference: 2019 ESC Guidelines for the management of patients with supraventricular tachycardia.\">C) An irregularly irregular, chaotic wide QRS complex tachycardia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"AV dissociation is a hallmark of Ventricular Tachycardia, whereas AVRT relies on an intact 1:1 atrial-ventricular circuit. Reference: 2019 ESC Guidelines for the management of patients with supraventricular tachycardia.\">D) A narrow complex tachycardia exhibiting profound AV dissociation.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q9 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q9<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During an echocardiogram for suspected cardiac tamponade, several 2D and Doppler signs are evaluated. Which finding is considered the most SENSITIVE (often the earliest) 2D echocardiographic sign of cardiac tamponade?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"RV diastolic collapse is highly SPECIFIC for tamponade and occurs slightly later as intrapericardial pressures continue to rise. Reference: 2015 ESC Guidelines for the diagnosis and management of pericardial diseases.\">A) Right Ventricular (RV) free wall diastolic collapse.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Right Atrial (RA) systolic collapse (occurring during late diastole\/early systole when the RA is at its lowest volume and pressure) is the earliest and most SENSITIVE 2D sign of impending cardiac tamponade. It precedes RV collapse and significant respiratory variation in valve flows. Reference: 2015 ESC Guidelines for the diagnosis and management of pericardial diseases.\">B) Right Atrial (RA) late diastolic\/early systolic collapse.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A plethoric IVC is a prerequisite sign indicating high right-sided pressures, but alone it lacks the dynamic sensitivity of chamber collapse for true tamponade physiology. Reference: 2015 ESC Guidelines for the diagnosis and management of pericardial diseases.\">C) A plethoric, non-collapsing Inferior Vena Cava (IVC).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"LV collapse almost never occurs due to its thick muscular wall and high operating pressures. Reference: 2015 ESC Guidelines for the diagnosis and management of pericardial diseases.\">D) Left Ventricular (LV) free wall systolic collapse.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q10 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q10<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient presenting with an acute STEMI is assessed using the Killip classification system to stratify their mortality risk. If the patient has audible rales over more than half of the lung fields and pulmonary edema on chest X-ray, what is their Killip Class?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Killip Class I indicates no clinical signs of heart failure (clear lungs, no S3). Reference: 2023 ESC Guidelines for the management of ACS.\">A) Killip Class I<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Killip Class II indicates mild heart failure (rales in the lower half of lung fields, presence of S3 gallop, or elevated JVP). Reference: 2023 ESC Guidelines for the management of ACS.\">B) Killip Class II<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Killip Class III is defined by frank, severe pulmonary edema with rales extending over more than 50% of the lung fields. (Class IV is cardiogenic shock). Reference: 2023 ESC Guidelines for the management of ACS.\">C) Killip Class III<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Killip Class IV is defined by cardiogenic shock (hypotension, peripheral vasoconstriction, oliguria, cyanosis). Reference: 2023 ESC Guidelines for the management of ACS.\">D) Killip Class IV<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q11 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q11<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          When screening a hypertensive patient for Primary Hyperaldosteronism (Conn&#8217;s Syndrome), which biochemical profile is the diagnostic hallmark?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"High renin with high aldosterone indicates secondary hyperaldosteronism (e.g., renal artery stenosis). Reference: 2018 ESC\/ESH Guidelines for the management of arterial hypertension.\">A) High Plasma Renin Activity (PRA) and high Plasma Aldosterone Concentration (PAC).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Primary hyperaldosteronism is characterized by autonomous, unregulated secretion of aldosterone from the adrenal glands. This directly suppresses renin secretion via negative feedback. Therefore, the screening hallmark is an elevated Plasma Aldosterone Concentration (PAC) paired with a profoundly suppressed Plasma Renin Activity (PRA), yielding a highly elevated Aldosterone-to-Renin Ratio (ARR &gt; 20 or 30 depending on lab units). Reference: 2018 ESC\/ESH Guidelines for the management of arterial hypertension.\">B) High Plasma Aldosterone Concentration (PAC) with suppressed\/low Plasma Renin Activity (PRA).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This profile is seen in Liddle syndrome or apparent mineralocorticoid excess (AME). Reference: 2018 ESC\/ESH Guidelines for the management of arterial hypertension.\">C) Suppressed Plasma Aldosterone Concentration (PAC) and suppressed Plasma Renin Activity (PRA).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"High renin and low aldosterone might be seen in Addison's disease or ACE inhibitor use. Reference: 2018 ESC\/ESH Guidelines for the management of arterial hypertension.\">D) High Plasma Renin Activity (PRA) with suppressed Plasma Aldosterone Concentration (PAC).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q12 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q12<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          According to the Modified Duke Criteria for the diagnosis of Infective Endocarditis, which of the following is considered a MAJOR criterion?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Fever &gt; 38\u00b0C is a minor criterion. Reference: 2023 ESC Guidelines for the management of endocarditis.\">A) Documented fever &gt; 38.0\u00b0C (100.4\u00b0F).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Janeway lesions (vascular phenomena) and Osler nodes (immunologic phenomena) are minor criteria. Reference: 2023 ESC Guidelines for the management of endocarditis.\">B) The presence of Janeway lesions or Osler nodes on physical exam.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A predisposing heart condition (e.g., prosthetic valve) or IV drug use is a minor criterion. Reference: 2023 ESC Guidelines for the management of endocarditis.\">C) A history of intravenous drug use or a prosthetic heart valve.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The two primary MAJOR criteria are: 1) Typical microorganisms (e.g., S. aureus, Viridans strep) isolated from two separate blood cultures, and 2) Evidence of endocardial involvement on imaging (e.g., oscillating intracardiac mass\/vegetation, abscess, or new dehiscence of a prosthetic valve on Echocardiography). Reference: 2023 ESC Guidelines for the management of endocarditis.\">D) Evidence of an oscillating intracardiac mass (vegetation) or abscess on Echocardiography.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q13 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q13<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with known Vasospastic (Prinzmetal) Angina presents to the clinic. Which class of medications is strictly CONTRAINDICATED as it can exacerbate coronary artery spasm?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"DHP CCBs are first-line therapy for vasospastic angina. Reference: 2023 ESC Guidelines for the management of ACS.\">A) Dihydropyridine Calcium Channel Blockers (e.g., Amlodipine).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Long-acting nitrates are a standard therapy for preventing vasospasm. Reference: 2023 ESC Guidelines for the management of ACS.\">B) Long-acting Nitrates (e.g., Isosorbide mononitrate).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Non-selective Beta-blockers (like Propranolol) block beta-2 mediated vasodilation, leaving alpha-1 mediated vasoconstriction unopposed. This can dramatically worsen coronary vasospasm and is strictly contraindicated in Prinzmetal angina. Reference: 2023 ESC Guidelines for the management of ACS.\">C) Non-selective Beta-blockers (e.g., Propranolol).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Statins are recommended for endothelial stabilization, regardless of plaque burden. Reference: 2023 ESC Guidelines for the management of ACS.\">D) Statins (e.g., Rosuvastatin).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q14 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q14<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During physical examination, a &#8220;Pulsus Bisferiens&#8221; (a biphasic pulse with two palpable systolic peaks) is classically palpated in the carotid arteries of patients with which specific condition?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Severe isolated AS causes a 'pulsus parvus et tardus' (weak and delayed pulse). Reference: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.\">A) Severe, isolated calcific Aortic Stenosis.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Pulsus bisferiens (a double-peaking systolic pulse) is classically seen in two conditions: 1) Combined severe Aortic Regurgitation and Aortic Stenosis (where a large stroke volume is ejected rapidly, creates a venturi dip, and rebounds) and 2) Hypertrophic Obstructive Cardiomyopathy (HOCM) due to dynamic mid-systolic obstruction causing a dip and secondary rebound pressure wave. Reference: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.\">B) Severe Aortic Regurgitation (or combined AS\/AR) and Hypertrophic Obstructive Cardiomyopathy (HOCM).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Cardiac tamponade classically causes Pulsus Paradoxus (an exaggerated drop in systolic BP with inspiration). Reference: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.\">C) Acute Cardiac Tamponade.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Severe LV systolic failure causes Pulsus Alternans (alternating strong and weak beats). Reference: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.\">D) Severe Left Ventricular systolic failure (LVEF &lt; 20%).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q15 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q15<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient on long-term Amiodarone therapy for recurrent VT requires routine systemic toxicity screening. Which specific parameter on Pulmonary Function Testing (PFTs) is the most sensitive marker for early amiodarone-induced pulmonary toxicity?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"FEV1\/FVC assesses for obstructive lung disease (e.g., COPD, asthma), not the interstitial process of amiodarone toxicity. Reference: 2022 ESC Guidelines for the management of patients with ventricular arrhythmias.\">A) A decrease in the FEV1\/FVC ratio.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Amiodarone causes an interstitial pneumonitis\/fibrosis. The earliest and most sensitive marker on PFTs is a significantly decreased Diffusing Capacity for Carbon Monoxide (DLCO), typically dropping by &gt;= 20% from baseline, often occurring before changes in total lung volumes or overt symptoms. Reference: 2022 ESC Guidelines for the management of patients with ventricular arrhythmias.\">B) A significant decrease in the Diffusing Capacity for Carbon Monoxide (DLCO).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"TLC decreases late in the fibrotic stage, making it less sensitive for early detection than DLCO. Reference: 2022 ESC Guidelines for the management of patients with ventricular arrhythmias.\">C) An isolated decrease in Total Lung Capacity (TLC) with normal diffusion.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Peak expiratory flow rate evaluates large airway obstruction. Reference: 2022 ESC Guidelines for the management of patients with ventricular arrhythmias.\">D) A decrease in Peak Expiratory Flow Rate (PEFR).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q16 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q16<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In evaluating Atrial Septal Defects (ASDs), the ECG can provide critical clues to the anatomical subtype. How do the frontal plane QRS axes typically differ between an Ostium Secundum ASD and an Ostium Primum ASD?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This is the reverse of the true pattern. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">A) Secundum ASDs show Left Axis Deviation; Primum ASDs show Right Axis Deviation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Ostium Secundum ASDs (the most common type) cause right ventricular volume overload and hypertrophy, typically resulting in Right Axis Deviation (RAD) and incomplete RBBB. Ostium Primum ASDs are part of the endocardial cushion defect spectrum and involve an inferior displacement of the AV node and early branching of the left bundle, classically causing a marked Left Axis Deviation (LAD) alongside the RBBB pattern. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">B) Secundum ASDs show Right Axis Deviation; Primum ASDs show Left Axis Deviation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Primum ASDs almost universally display LAD. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">C) Both subtypes uniformly present with extreme Right Axis Deviation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Secundum ASDs are heavily associated with RAD, not a normal axis. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">D) Both subtypes present with a normal QRS axis, differentiated only by P wave morphology.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q17 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q17<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with an acute Inferior STEMI and confirmed Right Ventricular (RV) infarction becomes acutely hypotensive (BP 75\/40 mmHg) with clear lung fields. Which standard ACS medication is strictly CONTRAINDICATED in this specific clinical scenario?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Aspirin is essential for all STEMIs and does not affect hemodynamics. Reference: 2023 ESC Guidelines for the management of ACS.\">A) Aspirin 300mg.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Statins are safe and standard. Reference: 2023 ESC Guidelines for the management of ACS.\">B) High-intensity Statins.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"In RV infarction, the right ventricle becomes stiff and fails as a pump, making left ventricular filling entirely dependent on high central venous return (preload). Nitroglycerin is a potent venodilator that reduces preload, which can cause a catastrophic and potentially fatal drop in cardiac output and blood pressure in these patients. Treatment is instead aggressive IV fluid loading. Reference: 2023 ESC Guidelines for the management of ACS.\">C) Nitroglycerin (Sublingual or Intravenous).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Unfractionated Heparin is safe and indicated. Reference: 2023 ESC Guidelines for the management of ACS.\">D) Unfractionated Heparin.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q18 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q18<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During Dobutamine Stress Echocardiography (DSE) to evaluate for myocardial viability in a region of akinetic muscle, a &#8220;biphasic response&#8221; is observed. What exactly does a biphasic response entail, and what does it predict?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This represents non-viable scar tissue (no response). Reference: 2017 ASE Guidelines for the Clinical Application of Echocardiography.\">A) No change in contractility at low doses, and no change at high doses; predicts lack of viability.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This represents sustained viability without flow-limiting ischemia. Reference: 2017 ASE Guidelines for the Clinical Application of Echocardiography.\">B) Improved contractility at low doses that continues to improve steadily at high doses; predicts normal coronary flow.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"A biphasic response occurs when an akinetic segment improves its contractility at low-dose dobutamine (proving the muscle is alive\/viable), but deteriorates and becomes akinetic again at high-dose dobutamine (proving the presence of flow-limiting ischemia). This is the most highly predictive pattern for functional recovery following surgical or percutaneous revascularization. Reference: 2017 ASE Guidelines for the Clinical Application of Echocardiography.\">C) Improved contractility at low doses, followed by worsening contractility at high doses; predicts viability with ischemia, and high likelihood of recovery post-revascularization.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Worsening immediately at low dose indicates severe ischemia but not a classic 'biphasic' viability pattern. Reference: 2017 ASE Guidelines for the Clinical Application of Echocardiography.\">D) Worsening contractility at low doses followed by improvement at high doses; predicts microvascular dysfunction.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q19 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q19<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with chronic Cor Pulmonale presents with severe right heart failure. By strict pathophysiological definition, which of the following mechanisms must NOT be the cause of the patient&#8217;s right ventricular failure for it to be classified as Cor Pulmonale?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"COPD is the most common cause of Cor Pulmonale. Reference: 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.\">A) Chronic Obstructive Pulmonary Disease (COPD).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Primary pulmonary arterial hypertension (PAH) is a classic cause of Cor Pulmonale. Reference: 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.\">B) Idiopathic Pulmonary Arterial Hypertension (PAH).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Cor pulmonale is defined strictly as an alteration in the structure and function of the right ventricle (RV) caused by a primary disorder of the respiratory system (lungs, vasculature, or chest wall). Right ventricular failure occurring secondary to Left Heart Disease (e.g., Mitral Stenosis, HFrEF) is specifically excluded from the definition of Cor Pulmonale. Reference: 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.\">C) Left-sided heart disease (e.g., severe Mitral Stenosis or Left Ventricular Failure).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"CTEPH is a vascular lung disease and a valid cause of Cor Pulmonale. Reference: 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.\">D) Chronic Thromboembolic Pulmonary Hypertension (CTEPH).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q20 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q20<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In the cardiac catheterization lab, Rotational Atherectomy (e.g., Rotablator) is considered for a complex Percutaneous Coronary Intervention (PCI). What is the primary angiographic indication to utilize this specific device?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Aspiration thrombectomy is used for fresh thrombus, not a high-speed diamond burr. Reference: 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization.\">A) A fresh, large-burden red thrombus in an acute STEMI.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Rotational atherectomy utilizes a diamond-tipped burr spinning at very high speeds (140,000-180,000 rpm). Its primary indication is for heavily calcified, rigid coronary lesions that are 'undilatable' with standard or non-compliant balloons, allowing for plaque modification (pulverizing superficial calcium) so a stent can be adequately expanded. Reference: 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization.\">B) Severely calcified, rigid lesions that cannot be crossed or dilated by standard balloons.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Soft, lipid-rich plaques are easily stented and atherectomy is unnecessary and potentially harmful (no-reflow). Reference: 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization.\">C) Soft, lipid-rich, non-calcified plaques in saphenous vein grafts.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Coronary dissection is treated with stenting to tack up the flap; atherectomy is contraindicated as it will worsen the dissection. Reference: 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization.\">D) A large spontaneous coronary artery dissection (SCAD) flap.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q21 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q21<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A 28-year-old patient with hypertension is noted to have significantly weaker pulses in the lower extremities compared to the upper extremities. A chest X-ray demonstrates the &#8220;Figure 3 sign&#8221;. What highly specific bony abnormality is typically seen on the CXR in this condition?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The diagnosis is Coarctation of the Aorta (indicated by radio-femoral delay and the Figure 3 sign on the aortic contour). Because of the severe narrowing in the descending aorta, blood bypasses the obstruction via the internal mammary and intercostal arteries. The dilated, pulsatile intercostal arteries erode the undersurface of the ribs, causing classic 'inferior rib notching' (usually ribs 3-8) on CXR. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">A) Inferior rib notching.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Superior rib notching is associated with connective tissue disorders (e.g., Marfan's or RA), not coarctation. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">B) Superior rib notching.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Water bottle sign indicates a massive pericardial effusion. Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">C) A massive &#8216;water bottle&#8217; cardiac silhouette.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Egg-on-a-string appearance is classic for Transposition of the Great Arteries (TGA). Reference: 2020 ESC Guidelines for the management of adult congenital heart disease.\">D) The &#8216;egg-on-a-string&#8217; appearance of the mediastinum.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q22 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q22<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Echocardiography is performed on a patient from a developing country presenting with exertional dyspnea and hemoptysis. The exam shows a &#8220;hockey-stick&#8221; appearance of the anterior mitral leaflet and restricted motion of the posterior leaflet. What is the diagnosis?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"MVP involves systolic bowing of redundant leaflets into the left atrium, not diastolic doming. Reference: 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease.\">A) Myxomatous Mitral Valve Prolapse.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Rheumatic Mitral Stenosis is characterized by commissural fusion and leaflet thickening. During diastole, the high left atrial pressure pushes the body of the anterior leaflet open, but the fused tip is held back, creating a characteristic 'doming' or 'hockey-stick' appearance in the parasternal long-axis view. The posterior leaflet is usually rigid and pulled anteriorly. Reference: 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease.\">B) Rheumatic Mitral Stenosis.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"MAC involves heavy calcification at the base\/annulus of the valve, usually preserving tip mobility and lacking commissural fusion. Reference: 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease.\">C) Severe Mitral Annular Calcification (MAC).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Endocarditis typically presents with mobile, oscillating masses (vegetations) and regurgitation, not diastolic doming. Reference: 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease.\">D) Infective Endocarditis of the Mitral Valve.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q23 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q23<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          When determining the pacing mode of a Permanent Pacemaker (e.g., VVI, DDD), what does the FIRST letter of the standard NBG code denote?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The chamber Sensed is the SECOND letter. Reference: 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.\">A) The chamber(s) where native intrinsic activity is Sensed.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The Response to sensing (Triggered, Inhibited) is the THIRD letter. Reference: 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.\">B) The Response to a sensed event (Inhibited or Triggered).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"In the NBG Pacemaker Code, the first letter designates the chamber(s) that are PACED (A = Atrium, V = Ventricle, D = Dual). The second letter is the chamber Sensed. The third letter is the Response to sensing (I = Inhibited, T = Triggered, D = Dual). Reference: 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.\">C) The chamber(s) that are actively Paced.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Rate modulation (R) is the FOURTH letter. Reference: 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.\">D) The presence or absence of Rate Modulation.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q24 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q24<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with decompensated heart failure is diagnosed with &#8220;Cold and Wet&#8221; cardiogenic shock. An inotrope is required to increase cardiac output. How does Milrinone act to improve contractility?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes the mechanism of Dobutamine. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">A) It directly stimulates Beta-1 adrenergic receptors.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Milrinone is a Phosphodiesterase-3 (PDE3) inhibitor. By inhibiting PDE3, it prevents the breakdown of cyclic AMP (cAMP) inside the myocyte. Increased cAMP leads to increased intracellular calcium, enhancing contractility (inotropy), and also causes vasodilation in vascular smooth muscle (inodilator). Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">B) It inhibits Phosphodiesterase-3 (PDE3), preventing the breakdown of intracellular cAMP.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes Digoxin. Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">C) It inhibits the Na+\/K+ ATPase pump, causing intracellular calcium accumulation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes Levosimendan (a calcium sensitizer). Reference: 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure.\">D) It directly sensitizes Troponin C to calcium without increasing overall intracellular calcium levels.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q25 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-indigo-950 text-violet-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-indigo-500\/30\">Q25<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During the physical examination of a patient with severe, chronic Aortic Regurgitation, the physician observes visible capillary pulsations in the patient&#8217;s fingernail beds when gentle pressure is applied. What is the eponym for this classic clinical sign?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Corrigan's pulse (or water-hammer pulse) refers to the rapidly rising and collapsing pulse felt at the carotid artery. Reference: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.\">A) Corrigan&#8217;s Pulse.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"De Musset's sign is the rhythmic bobbing of the head in synchrony with the heartbeat. Reference: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.\">B) De Musset&#8217;s Sign.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Traube's sign (pistol shot sound) is heard via stethoscope over the femoral arteries. Reference: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.\">C) Traube&#8217;s Sign.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Quincke's pulse (or sign) is the visible alternate blanching and flushing (capillary pulsation) observed in the nail beds (or lips) when light pressure is applied. It is a classic peripheral sign of the wide pulse pressure and hyperdynamic circulation seen in severe Aortic Regurgitation. Reference: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine.\">D) Quincke&#8217;s Pulse.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n  <\/div>\n<\/div>\n\n<script>\n  let mcq18Correct = 0;\n  let mcq18Answered = 0;\n  const mcq18Total = 25;\n\n  document.querySelectorAll('#mcq18-quiz-wrapper .quiz-card').forEach(card => {\n    const buttons = card.querySelectorAll('.opt-btn');\n    buttons.forEach(btn => {\n      btn.addEventListener('click', function() {\n        if (card.getAttribute('data-answered') === 'true') return;\n        card.setAttribute('data-answered', 'true');\n        mcq18Answered++;\n\n        document.getElementById('mcq18-answered-count').innerText = mcq18Answered;\n        const pct = (mcq18Answered \/ mcq18Total) * 100;\n        document.getElementById('mcq18-progress-bar').style.width = pct + '%';\n\n        buttons.forEach(b => {\n          b.disabled = true;\n          b.classList.remove('hover:bg-slate-900', 'cursor-pointer');\n          b.classList.add('opacity-50', 'cursor-not-allowed');\n        });\n\n        const isCorrect = this.getAttribute('data-correct') === 'true';\n        const explanation = this.getAttribute('data-explanation');\n\n        if (isCorrect) {\n          mcq18Correct++;\n          document.getElementById('mcq18-correct-count').innerText = mcq18Correct;\n          this.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n          this.classList.add('bg-emerald-950\/80', 'border-emerald-500', 'text-emerald-200', 'opacity-100', 'border-2');\n          this.innerHTML += ' <span class=\"font-bold\">&#10004; CORRECT!<\/span>';\n        } else {\n          this.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n          this.classList.add('bg-red-950\/80', 'border-red-500', 'text-red-200', 'opacity-100', 'border-2');\n          this.innerHTML += ' <span class=\"font-bold\">&#10006; INCORRECT<\/span>';\n\n          buttons.forEach(b => {\n            if (b.getAttribute('data-correct') === 'true') {\n              b.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n              b.classList.add('bg-emerald-950\/40', 'border-emerald-500\/55', 'text-emerald-200', 'opacity-100', 'border-2');\n              b.innerHTML += ' <span class=\"font-bold\">&#10004; (Correct)<\/span>';\n            }\n          });\n        }\n\n        const feedback = card.querySelector('.feedback-box');\n        feedback.innerHTML = `\n          <div class=\"font-extrabold uppercase tracking-widest text-xs mb-2 ${isCorrect ? 'text-emerald-400' : 'text-red-400'}\">\n            ${isCorrect ? 'Clinical Explanation & Reference' : 'Explanation, Correct Answer & Reference'}\n          <\/div>\n          <p class=\"m-0\">${explanation}<\/p>\n        `;\n        feedback.classList.remove('hidden');\n        feedback.classList.add('block', isCorrect ? 'bg-emerald-950\/45' : 'bg-red-950\/20', 'border-2', 'border-solid', isCorrect ? 'border-emerald-500\/30' : 'border-red-500\/30', 'text-slate-200', 'mt-4');\n      });\n    });\n  });\n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>\ud83e\uddec Advanced Cardiology Series &#8211; Part 18 Interactive Cardiology MCQs #18 Post-Graduate Level Clinical, Imaging, EP &amp; Cardio-Oncology Masterclass \ud83c\udfaf Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 A patient with chronic Heart Failure with Reduced Ejection Fraction (HFrEF) is being transitioned from an ACE inhibitor (Enalapril) to an ARNI (Sacubitril\/Valsartan). What is the strictly [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":68008,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","nfd_image_url":"","nfd_onboarding_generated":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-68007","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New Series of Interactive Cardiology MCQs 18 - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Series of Interactive Cardiology MCQs 18 - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"\ud83e\uddec Advanced Cardiology Series &#8211; Part 18 Interactive Cardiology MCQs #18 Post-Graduate Level Clinical, Imaging, EP &amp; Cardio-Oncology Masterclass \ud83c\udfaf Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 A patient with chronic Heart Failure with Reduced Ejection Fraction (HFrEF) is being transitioned from an ACE inhibitor (Enalapril) to an ARNI (Sacubitril\/Valsartan). What is the strictly [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-30T05:25:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-30T05:25:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-18.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1208\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-18\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-18\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"New Series of Interactive Cardiology MCQs 18\",\"datePublished\":\"2026-10-30T05:25:46+00:00\",\"dateModified\":\"2026-10-30T05:25:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-18\\\/\"},\"wordCount\":1678,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-18\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-18.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-18\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-18\\\/\",\"name\":\"New Series of Interactive Cardiology MCQs 18 - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-18\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-18\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-18.jpg\",\"datePublished\":\"2026-10-30T05:25:46+00:00\",\"dateModified\":\"2026-10-30T05:25:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-18\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-18\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-18\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-18.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-18.jpg\",\"width\":1208,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-18\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Series of Interactive Cardiology MCQs 18\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Series of Interactive Cardiology MCQs 18 - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/","og_locale":"en_US","og_type":"article","og_title":"New Series of Interactive Cardiology MCQs 18 - All About Cardiovascular System and Disorders","og_description":"\ud83e\uddec Advanced Cardiology Series &#8211; Part 18 Interactive Cardiology MCQs #18 Post-Graduate Level Clinical, Imaging, EP &amp; Cardio-Oncology Masterclass \ud83c\udfaf Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 A patient with chronic Heart Failure with Reduced Ejection Fraction (HFrEF) is being transitioned from an ACE inhibitor (Enalapril) to an ARNI (Sacubitril\/Valsartan). What is the strictly [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-10-30T05:25:46+00:00","article_modified_time":"2026-10-30T05:25:48+00:00","og_image":[{"width":1208,"height":675,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-18.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"New Series of Interactive Cardiology MCQs 18","datePublished":"2026-10-30T05:25:46+00:00","dateModified":"2026-10-30T05:25:48+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/"},"wordCount":1678,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-18.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/","url":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/","name":"New Series of Interactive Cardiology MCQs 18 - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-18.jpg","datePublished":"2026-10-30T05:25:46+00:00","dateModified":"2026-10-30T05:25:48+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-18.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-18.jpg","width":1208,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-18\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"New Series of Interactive Cardiology MCQs 18"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/68007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=68007"}],"version-history":[{"count":1,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/68007\/revisions"}],"predecessor-version":[{"id":68009,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/68007\/revisions\/68009"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/68008"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=68007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=68007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=68007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}